Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Medication abortion & mifepristone stories

Aug 31, 2026

Federal judge pauses Florida and Texas lawsuit seeking to restrict mifepristone access

A federal judge paused a lawsuit by Florida and Texas seeking to severely limit nationwide access to the abortion pill mifepristone while the Trump administration completes a review of the drug's approval.

Aug 31, 2026·2 sources
00
Jul 24, 2026

Federal Judge Orders FDA to Reconsider Mifepristone Prescribing Restrictions

A U.S. federal judge ruled that Biden-era FDA restrictions on prescribing the abortion drug mifepristone are unlawful and unjustified, ordering the Trump Administration to reconsider existing regulations. The decision comes as over 400 state lawmakers from all 50 states have signed an amicus brief demanding protection for telehealth abortion care access.

Jul 24, 2026·4 sources
00
Jun 5, 2026

FDA Launches Safety Study of Abortion Pill Mifepristone

The Food and Drug Administration has initiated a safety study of mifepristone, the abortion pill approved decades ago, as opponents push for new restrictions. The FDA's website currently states the drug is safe to use as indicated.

Jun 5, 2026·1 source
00
May 2, 2026

Federal Appeals Court Blocks Mailing of Abortion Pill Mifepristone

A federal appeals court has ruled that mifepristone, which is involved in most abortions in the U.S., can now only be distributed in person at clinics, blocking mail delivery of the medication.

May 2, 2026·1 source
00
Apr 8, 2026

Federal Judge Refuses to Block Mifepristone Mail Distribution, Orders FDA Review

A federal judge declined to block filling prescriptions for the abortion pill mifepristone by mail across the U.S., but ordered the FDA to complete a review of the practice.

Apr 8, 2026·1 source
00

Top claims

  • ▪The U.S. Court of Appeals for the 5th Circuit will hear arguments on September 9, 2026, in a separate lawsuit filed by Louisiana challenging mail-order mifepristone regulations
  • ▪Judge Reed O'Connor rejected a motion by drugmakers GenBioPro and Danco Laboratories to dismiss the Florida and Texas lawsuit
  • ▪The FDA first announced its safety review of mifepristone in 2025, and the study has reportedly been delayed until after the November 2026 midterm elections

People involved

Donald Trump

Subtopics

Abortion access & policy5Reproductive Health5Government and Regulatory Policy4Drug Approval and Clinical Trials3Drug Policy, Pricing & Approval3Regulatory compliance3Reproductive rights3FDA regulation & drug policy2AI policy1AI regulation & lawsuits1FDA drug approval process1FDA regulations1Federal court rulings1Healthcare access1Healthcare fraud & litigation1New drug application (NDA) process1Public healthcare1State-federal power conflicts1State-level AI laws1Trump administration1U.S. AI regulation1US health policy & drug pricing1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Strait of Hormuz blockage

148 stories

Trump administration

161 stories